Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Early identification and management of graft failure after unrelated cord blood transplantation

Bone Marrow Transplantation volume 42, pages 35–41 (2008)Cite this article

Abstract

Delayed hematologic recovery is common after unrelated donor umbilical cord blood transplants (UCBT). Clinically it is important to quickly differentiate slow engraftment from graft failure (GF). We report the engraftment data on 110 pediatric UCBT recipients. By day 28, 71 patients achieved an ANC >0.5 × 109 per liter, and 6 others died early without recovery. Of the remaining 33 patients who were still neutropenic, 20 eventually attained donor myeloid recovery, 3 died of transplant-related complications or recurrent leukemia and 10 survived without donor-derived hematopoiesis. These patients received a second UCBT 33–95 days after the first transplant, after additional immunosuppression. One patient died early, the remaining nine patients were engrafted; eight demonstrated complete, and one mixed, donor chimerism (with subsequent graft loss). Acute GVHD developed in three, and chronic GVHD in six of the eight engrafted patients. Two patients developed EBV-lymphoproliferative disorder. Infections, especially viral, were common and protracted. Six of 10 patients are alive, 165–1375 (median 1147) days after second UCBT. Chimerism studies correlated with subsequent engraftment course. Any result showing <5% donor cells was associated with irreversible graft loss. In conclusion, early second UCBT after primary GF is a feasible treatment option. Chronic GVHD and viral reactivation are common post transplant.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Rubinstein P, Carrier C . Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Baillieres Clin Haematol 2000; 13: 565–584.

    Article  CAS  Google Scholar 

  2. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NKC et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795–802.

    CAS  PubMed  Google Scholar 

  3. Thompson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703–2711.

    Google Scholar 

  4. Kernan NA, Carter SL, Wagner JE, Baxter-Lowe L, Wall D, Kapoor N et al. Umbilical cord blood transplantation in pediatric patients: results of the prospective, multi-institutional cord blood transplantation study (COBLT). Biol Blood Marrow Transplant 2006; 12 (Suppl 1): 14 (abst 33).

    Article  Google Scholar 

  5. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A et al. Unrelated donor cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003; 102: 4290–4297.

    Article  CAS  PubMed  Google Scholar 

  6. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.

    Article  PubMed  Google Scholar 

  7. Ohwada C, Nakaseko C, Ozawa S, Takeuchi M, Shono K, Koizumi M et al. Second cord blood transplantation with reduced-intensity conditioning for graft failure after first CBT for AML. Bone Marrow Transplant 2004; 34: 999–1000.

    Article  CAS  PubMed  Google Scholar 

  8. Fernandes J, Rocha V, Robin M, Peffault de Latour R, Traineau R, Devergie A et al. Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation. Br J Haematol 2007; 137: 248–251.

    Article  PubMed  Google Scholar 

  9. Mizutani E, Narimatsu H, Murata M, Tomita A, Kiyoi H, Naoe T . Successful second cord blood transplantation using fludarabine and cyclophosphamide as a preparative regimen for graft rejection following reduced-intensity cord blood transplantation. Bone Marrow Transplant 2007; 40: 85–87. April 23 (e-pub ahead of print).

    Article  CAS  PubMed  Google Scholar 

  10. Narimatsu H, Kami M, Miyakoshi S, Murashige N, Yuji K, Hamaki T et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2005; 132: 36–41.

    Article  Google Scholar 

  11. Shimada K, Narimatsu H, Morishita Y, Kohno A, Saito S, Kato Y . Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient. Bone Marrow Transplant 2006; 37: 787–788.

    Article  CAS  PubMed  Google Scholar 

  12. Davies S, Weisdorf DJ, Haake RJ, Kersey JH, McGlave PB, Ramsey NKC et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: 73–77.

    CAS  PubMed  Google Scholar 

  13. Guardiola P, Kuentz M, Garban F, Blaise D, Reiffers J, Attal M et al. Second early allogeneic stem cell transplantation for graft failure in acute leukemia, chronic myeloid leukemia and aplastic anemia. Br J Haematol 2000; 111: 292–302.

    Article  CAS  PubMed  Google Scholar 

  14. Remberger M, Ringden O, Ljungman P, Hagglund H, Winiarski J, Lonnqvist B et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 22: 73–78.

    Article  CAS  PubMed  Google Scholar 

  15. Grandage VL, Cornish JM, Pamphilon DH, Potter MN, Steward CG, Oakhill A et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation. Bone Marrow Transplant 1998; 21: 687–690.

    Article  CAS  PubMed  Google Scholar 

  16. Bolger GB, Sullivan KM, Storb R, Witherspoon RP, Weiden PL, Stewart P et al. Second marrow infusion for poor graft function after allogeneic marrow transplantation. Bone Marrow Transplant 1986; 1: 21–30.

    CAS  PubMed  Google Scholar 

  17. Wolff SN . Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002; 29: 545–552.

    Article  CAS  PubMed  Google Scholar 

  18. Barker JN, Weisdorf DJ, DeFor TE, Blazer BR, Miller JS, Wagner JE . Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915–1919.

    Article  CAS  PubMed  Google Scholar 

  19. Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O'Brien MR et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005; 11: 362–370.

    Article  PubMed  Google Scholar 

  20. Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002; 100: 2005–2011.

    CAS  PubMed  Google Scholar 

  21. Parody R, Martino R, Rovira M, Vazquez L, Vazquez MJ, de la Camara R et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734–748.

    Article  PubMed  Google Scholar 

  22. Barker JN, Martin PL, Coad JE, DeFor TE, Trigg ME, Kurtzberg J et al. Low incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395–399.

    Article  CAS  PubMed  Google Scholar 

  23. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874–2880.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192–1200.

    Article  CAS  PubMed  Google Scholar 

  25. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA . Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954–1963.

    CAS  PubMed  Google Scholar 

  26. Antin JH, Childs R, Filipovich AH, Giralt S, MacKinnon S, Spitzer T et al. . Biol Blood Marrow Transplant 2001; 7: 473–485.

    Article  CAS  PubMed  Google Scholar 

  27. Bader P, Holle W, Klingebiel T, Handgretinger R, Benda N, Schlegel PG et al. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant 1997; 19: 697–702.

    Article  CAS  PubMed  Google Scholar 

  28. Cimino G, Rapanotti MC, Elia L, Lori AP, Gugliemi C, Screnci M et al. A prospective molecular study of chimerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimerism predicts graft failure with or without early autologous reconstitution in cord blood recipients. Br J Haematol 1999; 104: 770–777.

    Article  CAS  PubMed  Google Scholar 

  29. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher incidence of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 1986; 67: 811–816.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Stem Cell Transplantation, Texas Transplant Institute, San Antonio, TX, USA

    K W Chan, M S Grimley, C Taylor & D A Wall

  2. Methodist Children's Hospital, San Antonio, TX, USA

    K W Chan, M S Grimley, C Taylor & D A Wall

Authors
  1. K W Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M S Grimley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D A Wall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K W Chan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, K., Grimley, M., Taylor, C. et al. Early identification and management of graft failure after unrelated cord blood transplantation. Bone Marrow Transplant 42, 35–41 (2008). https://doi.org/10.1038/bmt.2008.40

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.40

Keywords

This article is cited by

Search

Advanced search

Quick links